Profile data is unavailable for this security.
About the company
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
- Revenue in USD (TTM)46.58m
- Net income in USD15.63m
- Incorporated1978
- Employees169.00
- LocationUtah Medical Products Inc7043 S 300 WestMIDVALE 84047United StatesUSA
- Phone+1 (801) 566-1200
- Fax+1 (801) 566-7305
- Websitehttp://www.utahmed.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senseonics Holdings Inc | 24.04m | -80.46m | 182.83m | 132.00 | -- | 285.70 | -- | 7.61 | -0.1323 | -0.1323 | 0.0395 | 0.0714 | 0.1815 | 2.58 | 5.99 | 182,113.60 | -60.74 | -73.65 | -74.52 | -106.97 | 12.04 | -40.41 | -334.69 | -649.86 | 2.89 | -10.93 | 0.5802 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| Nevro Corp | 426.10m | -77.44m | 189.40m | 1.22k | -- | 0.6891 | -- | 0.4445 | -2.12 | -2.12 | 11.69 | 7.37 | 0.7266 | 1.11 | 5.93 | 350,697.90 | -13.21 | -13.64 | -15.59 | -16.68 | 68.06 | 68.54 | -18.18 | -20.67 | 3.53 | -28.95 | 0.4433 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| SANUWAVE Health Inc | 24.90m | -3.43m | 189.46m | 31.00 | -- | -- | -- | 7.61 | -3.55 | -3.55 | 8.17 | -12.56 | 1.24 | 3.90 | 8.34 | 803,064.50 | -17.07 | -136.54 | -- | -- | 71.57 | 69.13 | -13.79 | -189.60 | 0.0999 | 0.1199 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| Trubridge Inc | 336.56m | -52.28m | 202.71m | 3.22k | -- | 1.12 | -- | 0.6023 | -3.68 | -3.68 | 23.64 | 12.12 | 0.7947 | 196.76 | 5.88 | 104,553.30 | -12.66 | 1.25 | -14.34 | 1.41 | 48.70 | 50.40 | -15.93 | 1.56 | 1.76 | 0.6115 | 0.4985 | 45.06 | 3.91 | 3.89 | -387.73 | -- | 88.71 | -- |
| Sight Sciences Inc | 79.40m | -52.32m | 212.80m | 214.00 | -- | 2.09 | -- | 2.68 | -1.06 | -1.06 | 1.61 | 2.03 | 0.474 | 1.53 | 4.18 | 371,004.70 | -31.24 | -38.78 | -34.01 | -42.20 | 85.80 | 80.74 | -65.90 | -105.14 | 10.50 | -26.50 | 0.2494 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Electromed Inc | 54.72m | 5.15m | 214.24m | 174.00 | 44.02 | 4.94 | 35.76 | 3.92 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
| Accuray Inc | 444.20m | -20.08m | 216.21m | 987.00 | -- | 4.77 | -- | 0.4868 | -0.2032 | -0.2032 | 4.48 | 0.4503 | 0.9353 | 2.01 | 5.25 | 450,054.70 | -4.23 | -1.37 | -7.35 | -2.33 | 31.09 | 36.43 | -4.52 | -1.55 | 0.8655 | -0.0936 | 0.7901 | -- | -0.2355 | 1.29 | -67.51 | -- | -3.54 | -- |
| Neuropace Inc | 71.82m | -29.90m | 219.27m | 171.00 | -- | 22.14 | -- | 3.05 | -1.09 | -1.09 | 2.61 | 0.3392 | 0.7305 | 1.74 | 6.49 | 419,994.20 | -30.41 | -- | -34.66 | -- | 74.15 | -- | -41.63 | -- | 5.47 | -4.37 | 0.8565 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| Orchestra Biomed Holdings Inc | 2.08m | -55.58m | 233.76m | 56.00 | -- | 5.02 | -- | 112.44 | -1.57 | -1.57 | 0.0586 | 1.23 | 0.021 | 1.34 | 16.57 | 37,125.00 | -56.06 | -- | -64.66 | -- | 92.02 | -- | -2,673.26 | -- | 4.58 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Utah Medical Products, Inc. | 46.58m | 15.63m | 236.13m | 169.00 | 15.68 | 1.92 | 11.94 | 5.07 | 4.33 | 4.33 | 12.92 | 35.45 | 0.3576 | 1.99 | 12.81 | 275,609.50 | 12.00 | 12.69 | 12.43 | 13.19 | 58.99 | 61.57 | 33.56 | 30.51 | 23.68 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| LifeMD Inc | 178.28m | -26.60m | 251.95m | 207.00 | -- | -- | -- | 1.41 | -0.7004 | -0.7004 | 4.70 | -0.101 | 3.59 | 6.86 | 38.19 | 861,255.40 | -44.31 | -153.05 | -333.96 | -526.91 | 88.92 | 83.66 | -12.34 | -45.44 | 0.8327 | -8.19 | 1.13 | -- | 28.15 | 78.90 | 51.27 | -- | 143.64 | -- |
| Anika Therapeutics Inc | 164.17m | -97.52m | 252.78m | 357.00 | -- | 1.41 | -- | 1.54 | -6.64 | -6.64 | 11.14 | 12.24 | 0.5868 | 1.47 | 5.21 | 459,854.30 | -34.86 | -5.41 | -38.55 | -5.87 | 62.70 | 60.70 | -59.40 | -12.60 | 3.78 | -- | 0.00 | -- | 6.67 | 9.56 | -456.34 | -- | 3.11 | -- |
| Atlantic International Corp | 205.26m | -62.29m | 255.75m | 7.00 | -- | 9.77 | -- | 1.25 | -8.72 | -8.72 | 14.59 | 0.5222 | 2.91 | -- | 7.03 | 29,322,780.00 | -88.44 | -71.97 | -174.30 | -106.09 | 10.70 | 61.01 | -30.35 | -1,471.82 | -- | -1.33 | 0.7735 | -- | -100.00 | -- | -37.43 | -- | -- | -- |
| Inogen Inc | 326.65m | -92.44m | 263.04m | 834.00 | -- | 1.40 | -- | 0.8053 | -3.97 | -3.97 | 13.97 | 7.91 | 0.9562 | 6.85 | 7.49 | 391,670.30 | -27.06 | -8.23 | -33.51 | -9.53 | 42.56 | 44.54 | -28.30 | -10.31 | 2.37 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Jin Medical International Ltd | 20.13m | 2.91m | 286.48m | 245.00 | 98.18 | 10.92 | 94.00 | 14.23 | 0.0186 | 0.0186 | 0.1292 | 0.1676 | 0.5576 | 2.38 | 4.22 | 82,143.59 | 7.80 | 12.81 | 11.27 | 20.92 | 34.73 | 33.58 | 13.99 | 14.60 | 2.27 | -- | 0.2702 | 0.00 | 3.29 | -1.07 | 6.34 | -4.80 | -9.50 | -- |
| Zynex Inc | 193.67m | 4.82m | 286.93m | 1.10k | 60.84 | 8.15 | 30.68 | 1.48 | 0.1481 | 0.1481 | 5.91 | 1.11 | 1.40 | 2.57 | 7.05 | 176,059.10 | 3.48 | 14.58 | 4.06 | 17.52 | 80.20 | 79.62 | 2.49 | 10.44 | 3.15 | 4.15 | 0.6246 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
Data as of Nov 08 2024. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD
46.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 406.63k | 11.69% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 227.11k | 6.53% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 181.17k | 5.21% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 171.82k | 4.94% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 167.86k | 4.83% |
| Brandes Investment Partners LPas of 30 Jun 2024 | 116.52k | 3.35% |
| Geode Capital Management LLCas of 30 Jun 2024 | 88.56k | 2.55% |
| Ranger Investment Management LPas of 30 Sep 2024 | 86.55k | 2.49% |
| Rice, Hall, James & Associates LLCas of 30 Sep 2024 | 83.34k | 2.40% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 80.16k | 2.31% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
